121 related articles for article (PubMed ID: 2832403)
21. Identification of an endothelial cell binding site on kininogen domain D3.
Herwald H; Hasan AA; Godovac-Zimmermann J; Schmaier AH; Müller-Esterl W
J Biol Chem; 1995 Jun; 270(24):14634-42. PubMed ID: 7540175
[TBL] [Abstract][Full Text] [Related]
22. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
Wiggins RC
J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
[TBL] [Abstract][Full Text] [Related]
23. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor.
Shibayama Y; Reddigari SR; Teruya M; Nakamura K; Fukunaga Y; Ienaga K; Nishikawa K; Suehiro S; Kaplan AP
Biochem Pharmacol; 1998 Apr; 55(8):1175-80. PubMed ID: 9719471
[TBL] [Abstract][Full Text] [Related]
24. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
[TBL] [Abstract][Full Text] [Related]
25. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions.
Olson ST; Francis AM; Sheffer R; Choay J
Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292
[TBL] [Abstract][Full Text] [Related]
26. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells.
Martinez J; Rich E; Barsigian C
J Biol Chem; 1989 Dec; 264(34):20502-8. PubMed ID: 2573600
[TBL] [Abstract][Full Text] [Related]
27. Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets.
Jiang YP; Muller-Esterl W; Schmaier AH
J Biol Chem; 1992 Feb; 267(6):3712-7. PubMed ID: 1740422
[TBL] [Abstract][Full Text] [Related]
28. Mapping binding domains of kininogens on endothelial cell cytokeratin 1.
Shariat-Madar Z; Mahdi F; Schmaier AH
J Biol Chem; 1999 Mar; 274(11):7137-45. PubMed ID: 10066772
[TBL] [Abstract][Full Text] [Related]
29. High molecular weight kininogen binds to unstimulated platelets.
Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
[TBL] [Abstract][Full Text] [Related]
30. High molecular weight kininogen receptor.
Greengard JS; Griffin JH
Methods Enzymol; 1992; 215():369-82. PubMed ID: 1331710
[No Abstract] [Full Text] [Related]
31. Binding of heparin to human high molecular weight kininogen.
Björk I; Olson ST; Sheffer RG; Shore JD
Biochemistry; 1989 Feb; 28(3):1213-21. PubMed ID: 2713360
[TBL] [Abstract][Full Text] [Related]
32. Assembly and activation of the intrinsic fibrinolytic pathway on the surface of human endothelial cells in culture.
Lenich C; Pannell R; Gurewich V
Thromb Haemost; 1995 Aug; 74(2):698-703. PubMed ID: 8585009
[TBL] [Abstract][Full Text] [Related]
33. Factor XI, but not prekallikrein, blocks high molecular weight kininogen binding to human umbilical vein endothelial cells.
Baird TR; Walsh PN
J Biol Chem; 2003 Jun; 278(23):20618-23. PubMed ID: 12663668
[TBL] [Abstract][Full Text] [Related]
34. Rapid and cooperative binding of factor XII to human umbilical vein endothelial cells.
Schousboe I
Eur J Biochem; 2001 Jul; 268(14):3958-63. PubMed ID: 11453989
[TBL] [Abstract][Full Text] [Related]
35. Human neutrophils contain and bind high molecular weight kininogen.
Gustafson EJ; Schmaier AH; Wachtfogel YT; Kaufman N; Kucich U; Colman RW
J Clin Invest; 1989 Jul; 84(1):28-35. PubMed ID: 2738152
[TBL] [Abstract][Full Text] [Related]
36. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
Soker S; Fidder H; Neufeld G; Klagsbrun M
J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor.
Herwald H; Dedio J; Kellner R; Loos M; Müller-Esterl W
J Biol Chem; 1996 May; 271(22):13040-7. PubMed ID: 8662673
[TBL] [Abstract][Full Text] [Related]
38. Binding of activation of kinin-forming proteins on vascular endothelial cells.
Kaplan AP; Joseph K; Shibayama Y
Immunopharmacology; 1997 Jun; 36(2-3):201-7. PubMed ID: 9228547
[No Abstract] [Full Text] [Related]
39. Binding and endocytosis of heparin by human endothelial cells in culture.
Bârzu T; Molho P; Tobelem G; Petitou M; Caen J
Biochim Biophys Acta; 1985 May; 845(2):196-203. PubMed ID: 3995089
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
Joseph K; Ghebrehiwet B; Kaplan AP
Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
